Po-Jui Yu

Po-Jui Yu

Auto-generated profile, based on publicly available information

Po-Jui Yu

National Taiwan University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2005 in Annals of Surgery
Verified
Journal Article
Closed access
WLWei-Jei Lee
Wei-Jei Lee
PYPo-Jui Yu
Po-Jui Yu
WWWeu Wang
Weu Wang
TCTai-Chi Chen
Tai-Chi Chen
PWPo-Li Wei
Po-Li Wei
MHMing-Te Huang
Ming-Te Huang
This prospective, randomized trial compared the safety and effectiveness of laparoscopic Roux-en-Y gastric bypass (LRYGBP) and laparoscopic mini-gastric bypass (LMGBP) in the treatment of morbid obesity. LRYGBP has been the gold standard for the treatment of morbid obesity. While LMGBP has been reported to be a simple and effective treatment, data from a randomized trial are lacking. Eighty patients who met the NIH criteria were recruited and randomized to receive either LRYGBP (n = 40) or LMGBP (n = 40). The minimum postoperative follow-up was 2 years (mean, 31.3 months). Perioperative data were assessed. Late complication, excess weight loss, BMI, quality of life, and comorbidities were determined. Changes in quality of life were assessed using the Gastro-Intestinal Quality of Life Index (GIQLI). There was one conversion (2.5%) in the LRYGBP group. Operation time was shorter in LMGBP group (205 versus 148, P < 0.05). There was no mortality in each group. The operative morbidity rate was higher in the LRYGBP group (20% versus 7.5%, P < 0.05). The late complications rate was the same in the 2 groups (7.5%) with no reoperation. The percentage of excess weight loss was 58.7% and 60.0% at 1 and 2 years, respectively, in the LPYGBP group, and 64.9% and 64.4% in the LMGBP group. The residual excess weight <50% at 2 years postoperatively was achieved in 75% of patients in the LRYGBP group and 95% in the LMGBP group (P < 0.05). A significant improvement of obesity-related clinical parameters and complete resolution of metabolic syndrome in both groups were noted. Both gastrointestinal quality of life increased significantly without any significant difference between the groups. Both LRYGBP and LMGBP are effective for morbid obesity with similar results for resolution of metabolic syndrome and improvement of quality of life. LMGBP is a simpler and safer procedure that has no disadvantage compared with LRYGBP at 2 years of follow-up.

1 May 2004 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
WLWei-Jei Lee
Wei-Jei Lee
MHMing-Te Huang
Ming-Te Huang
PYPo-Jui Yu
Po-Jui Yu
WWWeu Wang
Weu Wang
TCTai-Chi Chen
Tai-Chi Chen

1 May 2006 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
WLWei-Jei Lee
Wei-Jei Lee
WWWeu Wang
Weu Wang
PYPo-Jui Yu
Po-Jui Yu
PWPo-Li Wei
Po-Li Wei
MHMing-Te Huang
Ming-Te Huang

16 January 2008 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SSShiow-Ching Shun
Shiow-Ching Shun
JCJeng-Fong Chiou
Jeng-Fong Chiou
YLYeur-Hur Lai
Yeur-Hur Lai
PYPo-Jui Yu
Po-Jui Yu
LWLin-Lin Wei
Lin-Lin Wei
YHYa-Li Hsiao
Ya-Li Hsiao

26 October 2007 in Journal of Advanced Nursing
Verified
Journal Article
Closed access
PDF file
MLMeei‐Fang Lou
Meei‐Fang Lou
YDYu‐Tzu Dai
Yu‐Tzu Dai
GHGuey‐Shiun Huang
Guey‐Shiun Huang
PYPo‐Jui Yu
Po‐Jui Yu

1 October 2005 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
WWWeu Wang
Weu Wang
PYPo-Jui Yu
Po-Jui Yu
YLYi-Chi Lee
Yi-Chi Lee
PWPo-Li Wei
Po-Li Wei
WLWei-Jei Lee
Wei-Jei Lee